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The most important aspects of technological support of the radiation therapy of Ukraine are considered in ac-
cordance with the requirements of the IAEA. The reasons that influence the availability of radiotherapy for cancer 
patients in Ukraine are analyzed taking into account the experience of Grigoriev Institute for Medical Radiology of 
the National Academy of Medical Sciences of Ukraine. 
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INTRODUCTION 
The beam sources of radiation are applied in medi-
cine from the first years of the accelerators emergence. 
Now it is impossible to imagine modern oncology with-
out these technologies. But existence and maintenance 
of appropriate equipment requires a high level of the 
financial and technological support. The level of radia-
tion technologies development directly reflects the level 
of scientific and technical development and economic 
conditions in any country [1 - 3]. The current situation 
in the world on this subject is shown in Fig. 1.  
 
 
Fig. 1. Interrelation between GDP and number  
of EBRT equipment in the world 
The analysis of interrelation GDP level (the IMF, 
2014) and external-beam radiation (EBRT) equipment 
in the world (DIRAC IAEA) has shown that 67.9% of 
the world park of EBRT equipment are concentrated in 
10 most powerful countries with the greatest GDP 
(65.2% of world GDP). Direct compliance between the 
GDP level and the number of EBRT equipment is obvi-
ous. 
According to guidelines of IAEA it’s enough to have 
4 MV EBRT machines per 1 million of population for 
sufficient availability of radiation treatment [4]. The 
main types of megavoltage radiotherapy equipment cur-
rently are medical 6…18 MeV linear accelerators of 
electrons (linacs) and Co-60 machines. According to 
actual data of IAEA DIRAC Database there are more 
than 11648 linacs, 2156 Co-60 machines and 138 parti-
cle accelerators in use worldwide.  
Global trends indicate decrease of quantity of Co-60 
machines and more wide use of linacs.  EBRT linacs are 
more flexible in use and allow implement new technol-
ogies with high accuracy of dose delivery – IMRT, 
IGRT, ARC, tomotherapy, stereotaxic radiosurgery. But 
on the other hand linacs can be operated only by very 
qualified specialists, in good technological conditions. 
Thus this equipment and requirements for its mainte-
nance are much more complex than for previous simple 
Co-60 machines. Linac-based technologies can be used 
successfully if enough of resources for all workflow. 
Linacs are integrated into RT network and operate under 
control of modern computer systems with support of 
built-in imaging systems. Of course old Co-60 machines 
have significant drawbacks and limitations for RT. That 
is why ratio “linacs to Co-60 machines” can be used as 
indicator of technological level of radiotherapy and ef-
fectiveness of cancer patient’s care. For high developed 
regions (North America and Western Europe) the aver-
age ratio “linacs vs Co-60 machines” is near 96 to 4%, 
for Eastern Europe and North Asia – 60 to 40% respec-
tively. 
1. DEVELOPMENT OF EBRT IN UKRAINE  
Ukraine is classified by DIRAC IAEA as Low Mid-
dle Income country with level of availability 2.6 EBRT 
machines per 1 million of population. Now Ukraine has 
58 RT centers. As of the beginning of 2017 there were 
80 Co-60 machines and 25 linacs in use in Ukrainian 
hospitals, ratio “linacs vs Co-60 machines” is 24 to 
76%. It indicates significant technological problems in 
Ukrainian radiation medicine. 
Use of 125 EBRT machines cover only 65% needs 
of Ukrainian population in radiation treatment.  
During all years of existence of independent Ukraine 
use of Co-60 machines was predominant in radiotherapy 
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centers (Fig. 2). Even now we can’t overcome the prob-
lem of inaccessibility of modern linacs for wide clinical 
use in Ukraine [5]. Among used Co-60 machines 35% 
of them require immediate replacement of Co-60 source 
with simultaneous procedural service for the further use, 
16% machines are in use more than 30 years. 
Since 2014 Ukraine has lost control over 13 EBRT 
machines in occupied part of Donbass and 5 machines 
in Crimea (totally 17% of Ukrainian EBRT machines). 
So the catastrophic shortage of the RT equipment in 
Ukraine is obvious. 
The main reason for this situation is the shortage of 
state and regional financial resources on maintenance of 
high technologies in health care. In case of enough fi-
nancial resources the installation of the newest EBRT 
systems in Ukraine can be done as quickly as in Poland 
or Turkey where state programs of global RT upgrade 
were implemented under supervision of appropriate 
European institutions. 
As for efficient radiological staff Ukraine still has 
good personnel opportunities, scientific and educational 
support. Especially it is really to implement this tech-
nology in Kharkiv region thanks to comprehensive sup-
port of National Science Center Kharkiv Institute of 
Physics and Technology, Karazin Kharkiv National 
University, Kharkiv National University of Radio Elec-
tronics. 
Just Kharkiv has rich experience in development and 
application of particle accelerators.  The first in Ukraine 
in-room medical linac was mounted in 1991 in Kharkiv 
Grigoriev Scientific Research Institute for Medical Ra-
diology. Both 15 MeV photon and 10…15 MeV elec-
tron beams were available for clinical use (Fig. 3). 
Linac LUEV-15 M1 was developed and produced in 
NIIEFA (Yefremov Scientific Research Institute of 
Electrophysical Equipment). It allowed conventional 2D 
RT with high clinical capacity (up to 15 sec per patient). 
Several medical scientific research projects have been 
successfully performed during operation of LUEV-15 
M1 in Kharkiv Institute for Medical Radiology. 
The results of these researches proved that use of 
15 MeV photon beam for radical RT of lung cancers 
allow to improve results of treatment (90.4% of cases) 
and considerably reduce negative side effects in com-
parison with effects reached after treatment with use 
Co-60 machine (gamma radiation 1.25 MeV) [6]. 
Therefore clinical use of high energy linac for elimina-
tion of growth of some forms of tumors was justified 
and successful. But this technology was limited in use 
because maintenance of equipment was very complicat-
ed. It caused by complexity of linac design, primitive 
control, low reliability, quick hardware obsolescence 
and insufficient technical support. Problems of post-
soviet disintegration of technological infrastructure in 
1990th caused closure of short period of use of soviet 
linacs in Ukraine. 
The next attempt of returning of linacs to Ukrainian 
oncology centers was done in 2000
th
 (Fig. 4). Thanks to 
experience and knowledge gained in previous years 
Ukrainian technicians and radiologists have overcome 
difficulties of installation and start of new generation of 
linac-based EBRT equipment.  
 
 
Fig. 2. Co-60 machine ROCUS-AM in treatment room  
of Kharkiv Grigoriev Scientific Research Institute  
for Medical Radiology, since 1990 
 
Fig. 3. Linac LUEV-15 M1 in treatment room  
of Kharkiv Grigoriev Scientific Research Institute  
for Medical Radiology, since 1991  
 
Fig. 4. Linac Varian Clinac 600C in treatment room  
of Grigoriev Institute for Medical Radiology NAMS  
of Ukraine, since 2010 
Now all main linac-based EBRT equipment devel-
opers – Varian, Elekta, Accuray and Siemens – are pre-
sented in Ukraine (Fig. 5). Distribution of working 
EBRT linacs in Ukraine by key linac manufacturers is 
shown on Fig. 5,a. For comparison the global distribu-
tion of EBRT linacs worldwide is shown on Fig. 5,b.  
General correspondence between these two diagrams 
indicates that Ukraine follow global trends of EBRT 
linac market on qualitative structure. But quantitatively 
we have lack of this modern equipment in all regions of 
Ukraine except for Kyiv. All newest equipment 
(Figs. 6,b,c) is installed in private centers thus now it 
isn’t available for ordinary patients. 
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Fig. 5. Distribution of EBRT linacs by manufacturers: 
a – in Ukraine (DIRAC IAEA); b – worldwide  
(Zacks Small-Cap Research, 2016) 
a 
b 
c 
Fig. 6. New generation of RT linacs in Ukraine: 
a  Varian Novalis TX in Clinical Hospital “Pheopa-
niya”, Kyiv, since 2011; b – Accuray CyberKnife G4  
in Cyber Clinic of Spizhenko, Kapitanovka, since 2009; 
c – Accuray Tomo HD in Ukrainian Center of Tomo-
therapy, Kropyvnytskyi, since 2015  
2. IAEA GUIDELINES FOR UKRAINIAN  
EBRT SERVICE  
According to Recommendations of IAEA [7] basic 
radiation therapy services at a minimum should be made 
available to all patients with cancer who need them. 
Ukraine must overcome 35% shortage of EBRT  
equipment in the next years. During this process all in-
stalled and working megavolt EBRT equipment (both 
Co-60 machines and linacs) must cover needs of 
Ukrainian patients without stops and failures. It is nec-
essary to overcome disproportions in distribution of the 
equipment between regions. Radiation treatment has to 
become more available for population of Ternopil, 
Chernovtsi, Vinnytsia and Mykolaiv regions (level of 
EBRT equipment less than 25%); Lviv, Ivano-
Frankivsk, Odessa, Kharkiv regions (level of EBRT 
equipment is near 30%). All working Co-60 machines 
must be recharged by new Co-60 sources according to 
technical requirements and be in use till the new linacs 
will be installed. 
 Ukraine must implement modern education and 
training programs to enable good quality radiation ther-
apy services. Of course it is necessary to provide ade-
quate salary levels to retain staff of existing RT depart-
ments and grow new generation of specialists for 
maintenance of the newest smart EBRT systems.  
Implementation of adequate QA/QC program for 
EBRT is necessary condition for improvement of RT 
service in Ukraine. 
Ukrainian RT specialists must clearly define which 
cancer outcomes are expected to be improved by the 
introduction of advanced technologies.  
As an example it’s necessary to consider daily ca-
pacity of every EBRT machine according with the cho-
sen technology (E.V. Titovich, I.G. Tarutin, 2014):  
- 2D RT needs 15 min per patient; 
- 3D CRT needs 20 min per patient; 
- IMRT needs 25 min per patient; 
- IGRT needs 35 min per patient; 
- SRT needs 40 min per patient. 
During two-shift working day RT department can 
treat no more than 38 patients with use of 100% high-
tech EBRT or 64 patients if rate of high-tech EBRT is 
60% or 100 patients if rate of high-tech EBRT is only 
20%. Thus no need to use only advanced technologies 
of EBRT for ordinary clinical cases. The specialists of 
Grigoriev Institute for Medical Radiology NAMS of 
Ukraine proposes as desirable to equip Ukrainian RT 
centers by 60% of conventional low-energy EBRT lin-
acs, by 30% of upgraded Co-60 machines and only by 
10% of high-tech, high-energy EBRT linacs and radio-
surgery equipment. It corresponds to actual structure of 
cancer incidence in Ukraine.  
CONCLUSIONS 
The main actual aspects of technical equipment of 
external-beam radiation therapy in Ukraine were dis-
cussed. Existing EBRT facilities were analyzed from the 
point of view of real needs of Ukrainian radiation on-
cology and some recommendations for improvement of 
RT service in Ukraine are proposed.  
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ДИСТАНЦИОННАЯ ЛУЧЕВАЯ ТЕРАПИЯ В УКРАИНЕ. ТЕНДЕНЦИИ И ПРОБЛЕМЫ 
В.П. Старенький, А.А. Петриченко, Л.А. Аверьянова  
Наиболее важные аспекты технологической поддержки лучевой терапии в Украине рассматриваются в 
соответствии с требованиями МАГАТЭ. Обстоятельства, влияющие на доступность радиотерапии для онко-
пациентов в Украине, анализируются с учетом опыта Института медицинской радиологии им. С.П. Григорь-
ева Национальной академии медицинских наук Украины.   
ДИСТАНЦІЙНА ПРОМЕНЕВА ТЕРАПІЯ В УКРАЇНІ. ТЕНДЕНЦІЇ ТА ПРОБЛЕМИ 
В.П. Старенький, О.О. Петриченко, Л.О. Авер’янова  
Найбільш важливі аспекти технологічної підтримки променевої терапії в Україні розглядаються відпові-
дно до вимог МАГАТЕ. Обставини, що впливають на доступність радіотерапії для онкопацієнтів в Україні, 
аналізуються з урахуванням досвіду Інституту медичної радіології ім. С.П. Григор’єва Національної акаде-
мії медичних наук України. 
